# Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine Therapy

> **NCT01037166** · PHASE2 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 84 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Entecavir

## Key facts

- **NCT ID:** NCT01037166
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** 2005-02
- **Final completion:** 2005-02
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2011-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01037166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01037166, "Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01037166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*